Edwards Lifesciences Free Cash Flow Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 133.67  0.58  0.43%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Free Cash Flow of Edwards Lifesciences Corporation with missing and latest data points interpolated. Free Cash Flow is a measure of financial performance calculated as Net Cash Flow from Operations minus Capital Expenditure.
Free Cash Flow  10 Years Trend  
Increasing
Slightly volatile
 Free Cash Flow 
      Timeline 

Edwards Lifesciences Free Cash Flow Over Time

2016-12-31  528,300,000 
2017-12-31  528,300,000 
2018-12-31  513,315,789 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  339,847,368
Geometric Mean  260,256,260
Coefficient Of Variation  72.95
Mean Deviation  197,066,397
Median  253,100,000
Standard Deviation  247,935,235
Range  875,700,000
R Value  0.77
R Squared  0.59
Significance  0.002044
Slope  49,067,553

Currently Trending

V   
 NYQ 
Sold over 20 shares of
a day ago ago
Traded for 121.85
S   
 NYQ 
Purchased over 500 shares of
a day ago ago
Traded for 5.39
F   
 NYQ 
Purchased over 200 shares of
a day ago ago
Traded for 10.61